secwatch.observer — SEC 8-K summary
======================================

Issuer:     MILESTONE SCIENTIFIC INC. (MLSS)
CIK:        0000855683
Form:       8-K
Filed at:   2023-02-06T23:59:59+00:00
Accession:  0001437749-23-002584
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Scientific appoints Peter Milligan as part-time CFO effective Feb 1, 2023
--------------------------------------------------------------------------------

- Annual salary of $120,000 plus incentive bonus target of 40% of cash compensation payable in shares.
- Eligible for $100,000 in annual restricted stock ($50k Feb 1, $50k Aug 1) valued at closing price, issued 60 days post-termination.
- Milligan previously CFO at Melinta Therapeutics (led through Chapter 11), Exelis, and senior finance roles at ITT and AT&T.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/0001437749-23-002584-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/855683/000143774923002584/mlss20230206_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-002584

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer